ARCHIVES

FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy

This article is from The Cancer Letter archive.

Vol. 23 No. 11 | March 21, 1997

Download PDF Visit The Full Archive

Related Articles

Former DCRRC Chief Saunders Proposes Total Separation Of NCI Intramural, Extramural Research

February 10, 1978

In Brief: Senate Cancer Coalition Hearing On Tamoxifin Planned for May 11; Bresnick Leads AACR

May 6, 1994

Congress Urges CMS To Soften Proposal For Coverage Of ESAs in Oncology.

July 20, 2007

Some Children With Hodgkin’s Disease Can Reduce Or Skip Radiation, Study Finds

October 29, 2004

Cancer Groups Endorse Pazdur For FDA Commissioner.

January 19, 2001

Severe Shortages Of Many Cancer Drugs Affecting Practices

November 19, 2010